Ocumetics Announces Completion of First Tranche of Debenture Private Placement for Net Proceeds of CA$2.82 Million
Medical Device Investing Ocumetics Technology: Pioneering Vision Enhancement with the Ocumetics Accommodating Lens
Life Science Investing Ocumetics Continues to Meet Significant Development Milestones; Lens Design Optimized for Upcoming First in Human Study
Life Science Investing Ocumetics Welcomes Dr. Doyle Stulting and Dr. Bart McRoberts to Board of Directors
Blue Lagoon Completes Second Tranche of Private Placement - Crescat Capital, Phoenix Gold Fund and Nicola Mining Increase Their Positions.
Cizzle Brands Corporation Reports $5.64 Million in Net Sales in the First Half of its 2025 Fiscal Year
